- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06093737
Strengthening Community Mental Health (COPE)
Reducing Disparities in Disaster-Related Mental Health Burden: Adaptation of a Multi-level Intervention to Build Community-based Response Capacity
The goal of this clinical trial is to examine the impact of the Communities Organizing for Power through Empathy (COPE) intervention in adults in communities having recently experienced or at risk of experiencing disaster. The main questions it aims to answer are:
- How does the COPE intervention affect individual mental health?
- How does the COPE intervention affect protective factors like coping and social support?
- How does the COPE intervention affect community resilience?
- How does delivery of the COPE intervention in partnership with a broad-based organization affect participant recruitment and retention, as well as outcomes?
Participants will participate in the three session COPE intervention. Researchers will compare individuals who participate in the COPE intervention to individuals who participate in house meetings to see if the COPE intervention improves mental health, coping, social support and community resilience. Researchers will also examine factors that affect implementation and intervention delivery.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This Community-Based Participatory Research (CBPR) study will follow a multiphase mixed-methods design to adapt, deliver, and assess the efficacy of the Communities Organizing for Power through Empathy (COPE) intervention model. We will partner with a broad-based community organization, Together Baton Rouge, to adapt the intervention model to fit the context of East Baton Rouge Parish (EBRP) and deliver it to members of religious and non-profit institutions.
The objectives of the multi-level COPE intervention model are twofold: (1) reduce psychological distress and amplify protective factors among individuals and communities at risk of experiencing disasters; and (2) build individual and community psychological support response capacity. The intervention will be delivered by trained Community Facilitators (CFs) at community institutions (i.e., churches) to their institutional members. We will conduct a stepped wedge cluster randomized controlled trial (SWCRCT) to examine the impact of the COPE intervention. Measures of mental health, coping, social support and community resilience will be assessed at four timepoints (see timeline for data collection timepoints). We will conduct interviews and group reflections with CFs and participants to gain insight into their experiences with the intervention.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jennifer L Scott, PhD, LCSW
- Phone Number: 225-578-0433
- Email: jenscott@lsu.edu
Study Contact Backup
- Name: Tara L Powell, PhD
- Phone Number: 217-300-0917
- Email: tlpowell@illinois.edu
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70802
- Recruiting
- Together Baton Rouge
-
Contact:
- Khalid Hudson
- Email: khudson.tbr@gmail.com
-
Sub-Investigator:
- Tara Powell, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individuals 18 years of age or older who are staff or members of an organization that is part of Together Baton Rouge and who participate in the intervention or are/were involved in the adaptation or implementation of the brief intervention in any capacity
Exclusion Criteria:
- Persons who are not 18 years of age or older and persons who are not staff or members of an organization that is part of Together Baton Rouge and/or not involved with the intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: COPE Intervention
Is a three session brief group psychoeducational intervention.
Session 1 is 4 hours, Session 2 and 3 are 1.5 hours.
It is delivered in groups of 8-15 people with sessions spaced 1 month apart.
|
A three session brief group psychoeducational intervention.
Session 1 is 4 hours, Session 2 and 3 are 1.5 hours.
It is delivered in groups of 8-15 people with sessions spaced 1 month apart.
|
|
Active Comparator: House Meeting Control
Is a 1.5 hour group meeting delivered in groups of 8-15 people spaced 1 month apart.
|
A three session brief group psychoeducational intervention.
Session 1 is 4 hours, Session 2 and 3 are 1.5 hours.
It is delivered in groups of 8-15 people with sessions spaced 1 month apart.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in perceived stress from baseline
Time Frame: T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
Measured using Perceived Stress Scale, a 10-item scale that measures the degree to which a person appraises situations in their life as stressful.
|
T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
|
Change in depression symptoms from baseline
Time Frame: T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
Measured using The Depression, Anxiety, and Stress Scale (DASS), a set of three self-report scales designed to measure depression, anxiety and stress.
|
T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
|
Change in anxiety symptoms from baseline
Time Frame: T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
Measured using The Depression, Anxiety, and Stress Scale (DASS), a set of three self-report scales designed to measure depression, anxiety and stress.
|
T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
|
Change in stress symptoms from baseline
Time Frame: T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
Measured using The Depression, Anxiety, and Stress Scale (DASS), a set of three self-report scales designed to measure depression, anxiety and stress.
|
T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
|
Change in perceived social support from baseline
Time Frame: T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
Measured using the Multidimensional Scale of Perceived Social Support (MSPSS) is a 12 item scale, assessing perceived social support and connection.
|
T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
|
Change in coping from baseline
Time Frame: T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
Measured using the Coping Self-Efficacy Scale (CSES) short form, a 12-item measure of confidence in managing stressors.
|
T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
|
Change in community resilience from baseline
Time Frame: T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
Measured using the Communities Advancing Resilience Toolkit (CART), a 21-item measure of community resilience items across 4 interrelated domains that both reflect and contribute to community resilience: (1) Connection and Caring; (2) Resources; (3) Transformative Potential; and (4) Disaster Management.
|
T1 (pre-intervention), T2 (1 month post-intervention), T3 (2 months post-intervention), T4 (3 months post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention acceptibility
Time Frame: After delivery of 3rd session
|
Measured using the Acceptability of Intervention Measure (AIM), a 4 item measure of agreement with intervention.
|
After delivery of 3rd session
|
|
Intervention appropriateness
Time Frame: After delivery of 3rd session
|
Measured using the Appropriateness Measure (IAM), a 4 item measure of agreement with the appropriateness of the intervention.
|
After delivery of 3rd session
|
|
Intervention feasibility
Time Frame: After delivery of 3rd session
|
Measured using the Feasibility of Intervention Measure (FIM), a 4 item measure of agreement with the feasibility of implementing the intervention.
|
After delivery of 3rd session
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interviews
Time Frame: From date of first intervention delivery until 3 months post-date of delivery of final intervention session
|
Semi-structured interviews about experience with participating in or facilitating the intervention
|
From date of first intervention delivery until 3 months post-date of delivery of final intervention session
|
|
Focus groups
Time Frame: From date of first intervention delivery until 3 months post-date of delivery of final intervention session
|
Periodic reflections conducted with community facilitators.
|
From date of first intervention delivery until 3 months post-date of delivery of final intervention session
|
|
Intervention fidelity
Time Frame: At each intervention session.
|
Assessed via facilitator observation using a structured fidelity questionnaire/form.
|
At each intervention session.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jennifer L Scott, PhD, LCSW, Louisiana State University Health Sciences Center in New Orleans
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRBAM-21-139105
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.